Suppr超能文献

FK506滴眼液联合角膜移植术治疗复发性蚕蚀性角膜溃疡的疗效

[Effect of FK506 eye-drop combined with keratoplasty on recurrent Mooren's ulcer].

作者信息

Xie Hanping, Chen Jiaqi, Lin Yuesheng, Liu Yongmin, Ye Chengtian

机构信息

Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060, China (Email:

出版信息

Zhonghua Yan Ke Za Zhi. 2002 Jan;38(1):13-5.

Abstract

OBJECTIVE

To observe the effect of FK506 eye-drop combined with keratoplasty on recurrent Mooren's ulcer.

METHODS

9 cases (15 eyes) of recurrent Mooren's ulcer were treated with topical FK506 eye-drop combined with keratoplasty. Of the 15 eyes, two of Mooren's ulcer smaller than half circle of the limbus were treated with 0.1% FK506 eye-drop. Among the other 13 eyes of the ulcer larger than half the circle of the limbus, 12 eyes were treated with excision of conjunctiva combined with lamellar keratoplasty. One eye with a central corneal perforation was treated with penetrating keratoplasty. FK506 eye-drop 0.1% was given to the 13 operated eyes after the re-epithelialization of the cornea. The effect of FK506 on recurrent Mooren's ulcer was observed. Measurements of FK506 in surgically resected cornea and conjunctiva, and aqueous humor of the operated eyes were performed using enzyme immunoassay procedure. Twelve cases of recurrent Mooren's ulcer treated with lamellar keratoplasty combined with topical 0.1% dexamethasone eye-drop were taken as control.

RESULTS

After application of 0.1% FK506 eye-drop, concentrations of 30 - 350 ng/g of FK506 were found in the cornea and conjunctiva, and no FK506 was measured in the aqueous humor. Nine cases (15 eyes) of recurrent Mooren's ulcer were all cured and no recurrence was observed during the follow-up time of 12 - 17 months. The vision of 5 eyes was improved more than 2 lines after the treatment. Seven eyes of Mooren's ulcer in the control group recurred.

CONCLUSION

0.1% FK506 eye-drop combined with keratoplasty is an effective treatment for recurrent Mooren's ulcer.

摘要

目的

观察FK506滴眼液联合角膜移植术治疗复发性蚕蚀性角膜溃疡的效果。

方法

对9例(15只眼)复发性蚕蚀性角膜溃疡患者采用局部应用FK506滴眼液联合角膜移植术治疗。15只眼中,2只蚕蚀性角膜溃疡小于角膜缘半圈的眼睛采用0.1% FK506滴眼液治疗。在其他13只溃疡大于角膜缘半圈的眼睛中,12只眼采用结膜切除联合板层角膜移植术治疗。1只角膜中央穿孔的眼睛采用穿透性角膜移植术治疗。13只手术眼在角膜重新上皮化后给予0.1% FK506滴眼液。观察FK506对复发性蚕蚀性角膜溃疡的疗效。采用酶免疫测定法对手术切除的角膜、结膜及手术眼房水中的FK506进行检测。选取12例采用板层角膜移植联合局部应用0.1%地塞米松滴眼液治疗的复发性蚕蚀性角膜溃疡患者作为对照。

结果

应用0.1% FK506滴眼液后,角膜和结膜中FK506浓度为30 - 350 ng/g,房水中未检测到FK506。9例(15只眼)复发性蚕蚀性角膜溃疡均治愈,在12 - 17个月的随访期内未观察到复发。治疗后5只眼的视力提高超过2行。对照组7只蚕蚀性角膜溃疡眼复发。

结论

0.1% FK506滴眼液联合角膜移植术是治疗复发性蚕蚀性角膜溃疡的有效方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验